Volume 14, Number 3—March 2008
Control of Hepatitis A by Universal Vaccination of Adolescents, Puglia, Italy
To the Editor: The incidence of hepatitis A in Italy has decreased in the past 2 decades because of improved sanitation and better living conditions (1). However, large outbreaks occurred in the 1990s in several southern regions of Italy, despite lower rates of infection among the general population (2–4). Person-to-person transmission has been recognized as a major factor in spread of this disease during this period (5).
Safe and highly effective hepatitis A vaccines have been available since 1995. Nevertheless, their use has been limited to the Western Hemisphere. Universal vaccination programs have been initiated only in the United States and Israel before 1998 (6). In 1998, after a large epidemic of hepatitis A, a vaccination program for toddlers and adolescents was initiated in Puglia in southeastern Italy, which has a population >4 million. This vaccine was offered free to all children 15–18 months of age and to adolescents 12 years of age. Until 2002, a combined hepatitis A plus B vaccine had been used for vaccination of adolescents as part of the national hepatitis B immunization program. In 2003, this hepatitis B vaccination program ended; only hepatitis A vaccines containing 1 antigen are now used. No catch-up vaccination campaign has been planned.
We analyzed disease surveillance and vaccine coverage data for 1991–2006 to evaluate the effect of such a vaccination program on hepatitis A incidence in persons in Puglia during the 9 years after initiation of the program. In the period before the vaccination program was initiated (1989–1997), annual incidence rates of hepatitis A in Puglia ranged from 4.3 to 139.8 cases/100,000. The average annual rate during this period was 49.5 cases/100,000. Two large outbreaks were reported in Puglia, the first in 1992 and the second in 1996–1997 (5). During the 9 years after start of the vaccination program (1998–2006), incidence of hepatitis A decreased from 22.8 cases/100,000 in 1998 to 0.7 cases/100,000 in 2006 (Figure). In the same period in other regions of Italy, incidence of hepatitis A was 5 cases/100,000, without any evident annual peak.
Since 2002, annual incidence rates in Puglia have remained at <2.8 cases/100,000, lower than those in the rest of Italy. This incidence has been observed in all age groups, without any differences between vaccinated and unvaccinated birth cohorts. Vaccination coverage among children 15–18 months of age was <20% during the period of the vaccination program. Coverage levels in adolescents reached 65% in the third year after the start of the program and then ranged from 57% to 72% (Figure).
Hepatitis A has been a serious public health problem in Puglia. This disease has had a detrimental effect on the local economy, which is based on tourism and trade of food products. However, since the vaccination program was started in 1998, disease incidence has decreased. During the study period, no other alternative prevention measures that could have had an effect on disease control were implemented.
High levels of vaccination coverage have not been achieved since the start of the campaign, and no catch-up vaccination program has been implemented. The decrease in hepatitis A incidence we observed involved all age groups, including those not covered by the vaccination program. This finding may indicate strong herd immunity, which would confirm what has been observed in other countries (7–9). However, there is uncertainty in interpreting current epidemiologic data. On the basis of available data, we cannot assess whether the current low incidence of hepatitis A in Puglia is caused by vaccination alone or in combination with other factors. We also cannot exclude the possibility that what we observed may have been an interepidemic period and that new episodes may occur in the future.
Our results indicate that local health authorities should be aware of possible increases in the incidence of hepatitis A in Puglia. An urgent catch-up vaccination program may be necessary to prevent future outbreaks. Moreover, a seroepidemiologic survey would be useful for assessing the size of the susceptible population and most vulnerable age groups.
- D’Amelio R, Mele A, Mariano A, Romanò L, Biselli R, Lista F, Hepatitis A, Italy [letter]. Emerg Infect Dis. 2005;11:1155–6.
- Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, Hepatitis A infection: a seroepidemiological study in young adults in north-east Italy. Eur J Epidemiol. 1997;13:875–8.
- Malfait P, Lopalco PL, Salmaso S, Germinario C, Salamina G, Quarto M, An outbreak of hepatitis A in Puglia, Italy, 1996. Euro Surveill. 1996;1:33–5.
- Lopalco PL, Malfait P, Salmaso S, Germinario C, Quarto M, Barbuti S, A persisting outbreak of hepatitis A in Puglia, Italy, 1996: epidemiological follow-up. Euro Surveill. 1997;2:31–2.
- Lopalco PL, Malfait P, Menniti-Ippolito F, Prato R, Germinario C, Chironna M, Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods. J Viral Hepat. 2005;12:315–21.
- Andre FE. Universal mass vaccination against hepatitis A. Curr Top Microbiol Immunol. 2006;304:95–114.
- Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005;294:194–201.
- Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005;294:202–10.
- Dominguez A, Salleras L, Carmona G, Batalla J. Effectiveness of a mass hepatitis A vaccination program in preadolescents. Vaccine. 2003;21:698–701.
- Figure. Incidence of hepatitis A in Puglia, Italy (gray line) compared with the rest of Italy (black line), 1998–2006, and hepatitis A vaccination coverage among adolescents in Puglia (dashed line), 1998–2005....
Suggested citation for this article: Lopalco PL, Prato R, Chironna M, Germinario C, Quarto M. Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy [letter]. Emerg Infect Dis [serial on the Internet]. 2008 Mar [date cited]. Available from http://wwwnc.cdc.gov/eid/article/14/3/07-0900
Please use the form below to submit correspondence to the authors or contact them at the following address:
Pietro Luigi Lopalco, Universita’ di Bari, Policlinico, Piazza Giulio Cesare, 70124 Bari, Italy;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 07, 2010
- Page last updated: July 07, 2010
- Page last reviewed: July 07, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)